Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3594293
Max Phase: Preclinical
Molecular Formula: C15H20Cl2O4
Molecular Weight: 335.23
Molecule Type: Small molecule
Associated Items:
ID: ALA3594293
Max Phase: Preclinical
Molecular Formula: C15H20Cl2O4
Molecular Weight: 335.23
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCC(=O)c1c(O)c(Cl)c(O)c(Cl)c1O
Standard InChI: InChI=1S/C15H20Cl2O4/c1-2-3-4-5-6-7-8-9(18)10-13(19)11(16)15(21)12(17)14(10)20/h19-21H,2-8H2,1H3
Standard InChI Key: JNFMULWPXXTGMO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 335.23 | Molecular Weight (Monoisotopic): 334.0739 | AlogP: 5.04 | #Rotatable Bonds: 8 |
Polar Surface Area: 77.76 | Molecular Species: ACID | HBA: 4 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 5.24 | CX Basic pKa: | CX LogP: 6.50 | CX LogD: 4.55 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.46 | Np Likeness Score: 0.73 |
1. Nguyen VH, Kikuchi H, Kubohara Y, Takahashi K, Katou Y, Oshima Y.. (2015) Development of novel DIF-1 derivatives that selectively suppress innate immune responses., 23 (15): [PMID:26122773] [10.1016/j.bmc.2015.06.027] |
Source(1):